Tumour necrosis factor alpha: a potential mediator of asthma.
about
Role of tumor necrosis factor in toluene diisocyanate asthmaChronic effects of air pollution on respiratory health in Southern California children: findings from the Southern California Children's Health StudySuppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.Cytokines in asthma.Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma.Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat.Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammationRole of metalloelastase in a model of allergic lung responses induced by cockroach allergen.Human eosinophil-airway smooth muscle cell interactions.New strategies in the treatment and prevention of allergic diseases.Transforming growth factor beta enhances respiratory syncytial virus replication and tumor necrosis factor alpha induction in human epithelial cells.Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: a meta-analysis.The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells.Thymic stromal lymphopoietin: master switch for allergic inflammation.Association between β+252 tumour necrosis factor polymorphism and asthma in western Saudi children.Associations of tumor necrosis factor G-308A with childhood asthma and wheezing.M2 Muscarinic acetylcholine receptor modulates rat airway smooth muscle cell proliferationAsthma in swimmers: a review of the current literature.Allergen-induced CD11b+ CD11c(int) CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model.Anti-TNFα therapy in inflammatory lung diseases.Genetic factors in the treatment of bronchial asthma.p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells.Inflammation, caveolae and CD38-mediated calcium regulation in human airway smooth muscle.Association of a lymphotoxin alpha gene polymorphism and atopy in Italian families.Role of transient receptor potential C3 in TNF-alpha-enhanced calcium influx in human airway myocytesShikonins, phytocompounds from Lithospermum erythrorhizon, inhibit the transcriptional activation of human tumor necrosis factor alpha promoter in vivo.17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma.Tumor necrosis factor-alpha increases airway smooth muscle oxidants production through a NADPH oxidase-like system to enhance myosin light chain phosphorylation and contractility.Involvement of p42/44 MAPK and RhoA protein in augmentation of ACh-induced bronchial smooth muscle contraction by TNF-alpha in rats.Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma.Regulation of store-operated Ca2+ entry by CD38 in human airway smooth muscle.Intranasal administration of recombinant progranulin inhibits bronchial smooth muscle hyperresponsiveness in mouse allergic asthma.Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma.Association of tumor necrosis factor polymorphisms with asthma and serum total IgE.
P2860
Q26160376-144AFB90-C87C-48DC-AAA0-C6B1E1328C9AQ27012624-B11897F0-E297-4EAF-9F01-319FC458D08FQ33321672-18C2A476-A17D-4FE4-8AD2-763E3019AFD1Q33717312-1BB171D8-EE95-4BC6-AEB6-4B01799C62FCQ34192914-F262255B-53B2-4258-A9B9-933C7D1A2128Q35042718-281A9C42-39A4-49EF-A641-BB79E193FACDQ35044257-E4362F9F-803D-42F0-BC23-92DC07FF30BAQ35103534-C9DF3180-9F2B-4AEB-8224-0C757B123A43Q35609658-A351B455-3F76-4F93-88B2-2D4B09F1535AQ35680646-0718CF5E-1832-4C37-966E-8E2E6D7BEA3EQ35784976-E973DFE1-9F7C-4E64-A436-403665E10DEFQ36203111-0D1E5A2D-3466-491C-BED5-EE58D49AA6D3Q36364561-598DA269-B78A-42DC-B361-D763EF2BA53FQ36375911-5A26126B-6636-40F4-B58D-C1C308A15969Q37062784-E00366CE-68A6-4203-863B-1A1155B7F240Q37144313-0CBA855F-6185-448F-AB2A-10BDE1DC2621Q37504293-F7B06969-4353-46C0-B01B-2D70AECAD9D6Q37819739-35DAF65B-AC65-4CDD-9D87-CA65EB55ED96Q38503730-9C2FAFB9-FD3E-4871-B54B-C73661713D20Q39392448-277355DA-6D6F-4C68-9A20-37E0E2239519Q40292888-80274F01-CFA3-4041-99AE-60D2A89DC7B1Q40910459-FCF514D4-F325-4F6C-8449-CD1F86F46FB2Q41960258-CDBCDF7A-C790-42C3-B6A6-38E49B81EA5BQ41975665-CCF127DE-AEB1-4110-BD64-8F411D0466B9Q41998755-E78204CD-D8D4-4BAF-977B-B311916FB4B8Q42453486-4FD33617-13E6-495C-9090-651FEAABFE92Q43222936-7CB591CE-555D-4508-8EC6-51951D21369CQ43918980-289F96C4-ED7D-4574-963A-DC6C9FFCA069Q43952430-4A892FD7-FE3B-4FFD-8D6A-F305DF8A7DC4Q45024975-52082869-DF71-4D05-BC97-371DD55E8653Q46198285-95D4E0F4-5956-4200-9655-7768405067EFQ46820311-EABDF815-59B1-44F8-8B63-B36D5C61D89EQ47690559-9FB7D0E0-7A90-4151-B8E7-17A96B9EF595Q47914770-FCEB4E46-1423-4B5E-9CB7-764BB6025DDFQ53646008-74EF269D-A181-49CE-8D6B-C2710D3D321B
P2860
Tumour necrosis factor alpha: a potential mediator of asthma.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Tumour necrosis factor alpha: a potential mediator of asthma.
@en
type
label
Tumour necrosis factor alpha: a potential mediator of asthma.
@en
prefLabel
Tumour necrosis factor alpha: a potential mediator of asthma.
@en
P1476
Tumour necrosis factor alpha: a potential mediator of asthma.
@en
P2093
P304
P356
10.1111/J.1365-2222.1995.TB03249.X
P577
1995-11-01T00:00:00Z